Toxic multinodular goiter surgery

Jump to navigation Jump to search

Toxic multinodular goiter Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic multinodular goiter from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic multinodular goiter surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic multinodular goiter surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic multinodular goiter surgery

CDC on Toxic multinodular goiter surgery

Toxic multinodular goiter surgery in the news

Blogs on Toxic multinodular goiter surgery

Directions to Hospitals Treating Toxic multinodular goiter

Risk calculators and risk factors for Toxic multinodular goiter surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2],Sunny Kumar MD [3]

Overview

  • Surgical intervention is not recommended for the management of [disease name].

OR

  • Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
  • The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
  • The feasibility of surgery depends on the stage of [malignancy] at diagnosis.

OR

  • Surgery is the mainstay of treatment for [disease or malignancy].

Surgery

Surgery is the mainstay of treatment for Toxic multinodular goiter.

Indications

Indications of surgery for multinodular goiter (MNG) includes:

  • Rapid enlargement of goiter
  • Rapidly enlarging thyroid nodules
  • FNAC is positive or suspicious of malignancy
  • Compression of trachea, esophagus, and other neck structures
  • Risk of malignancy
    • Suspicious cervical lymphadenopathy
    • Radiation exposure

Surgical procedures

Almost all multinodular goiters can be surgically removed through a collar incision. An additional thoracotomy is very rarely necessary.

Subtotal thyroidectomy

Bilateral subtotal thyroidectomy is effective in the treatment of multinodular goiter (with hot or cold nodules).

Unilateral Lobectomy

A unilateral lobectomy may be performed if only one thyroid lobe is enlarged.

Side effects of surgery

The side effects associated with thyroidectomy include:

  • Post-operative hypothyroidism
  • Recurrent laryngeal palsy
  • Hypocalcaemia


References

Template:WH Template:WS